Jack Slevin
Stock Analyst at Jefferies
(2.52)
# 2,502
Out of 5,182 analysts
5
Total ratings
75%
Success rate
13.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Slevin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Maintains: Buy | $44 → $37 | $31.50 | +17.46% | 1 | Nov 25, 2025 | |
| AGL agilon health | Maintains: Hold | $60 → $28 | $30.05 | -8.49% | 1 | Aug 15, 2025 | |
| MD Pediatrix Medical Group | Maintains: Buy | $14 → $18 | $23.07 | -21.98% | 2 | Nov 5, 2024 | |
| TOI The Oncology Institute | Assumes: Buy | $2.5 | $3.54 | -29.38% | 1 | Feb 26, 2024 |
Astrana Health
Nov 25, 2025
Maintains: Buy
Price Target: $44 → $37
Current: $31.50
Upside: +17.46%
agilon health
Aug 15, 2025
Maintains: Hold
Price Target: $60 → $28
Current: $30.05
Upside: -8.49%
Pediatrix Medical Group
Nov 5, 2024
Maintains: Buy
Price Target: $14 → $18
Current: $23.07
Upside: -21.98%
The Oncology Institute
Feb 26, 2024
Assumes: Buy
Price Target: $2.5
Current: $3.54
Upside: -29.38%